Kymera Therapeutics, Inc. ($KYMR)
Filing Information
| Accession Number | 0001193125-26-138372 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 1, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
36,000
Total Value
$1,194,820.38
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Mar 31, 2026 | Exercise/Conversion | 7,400 | $14.18 | $104,932.00 | 7,400 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 31, 2026 | Sale | 7,400 | $85.37 | $631,738.74 | 0 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 1, 2026 | Exercise/Conversion | 4,600 | $14.18 | $65,228.00 | 4,600 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 1, 2026 | Sale | 3,400 | $85.19 | $289,661.64 | 1,200 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 1, 2026 | Sale | 1,200 | $86.05 | $103,260.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Mar 31, 2026 | Exercise/Conversion | 7,400 | $0.00 | $0.00 | 4,600 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Apr 1, 2026 | Exercise/Conversion | 4,600 | $0.00 | $0.00 | 0 | Direct | โ | View Details |